Ali N Zaidi il 28/05/2026

Adult Congenital Heart Disease Workforce Challenges in the United States: Current State and Future Needs: Proceedings from the American College of Cardiology (ACC), Adult Congenital Pediatric Cardiology (ACPC) Council Adult Congenital Heart Disease Summit

JACC Adv. 2026 May;5(5):102776. doi: 10.1016/j.jacadv.2026.102776.ABSTRACTThe American College of Cardiology, through its Adult Congenital Pediatric Cardiology Council, convened an in-person Adult Congenital Heart Disease (ACHD) Workforce Summit on October 6th and 7th, 2024, in Washington, DC. This

Oriol Martínez-Torrecilla il 28/05/2026

Anticoagulation in venous thromboembolism and in atrial fibrillation

JRSM Cardiovasc Dis. 2026 May 24;15:20480040261431387. doi: 10.1177/20480040261431387. eCollection 2026 Jan-Dec.ABSTRACTAtrial fibrillation and venous thromboembolism cause significant morbidity and mortality worldwide. Therefore, anticoagulation therapy (even chronic) is mandatory for the broad maj

Ramon Moronkola il 28/05/2026

The need for equity in interventional cardiology care in sub-Saharan Africa

Front Cardiovasc Med. 2026 May 12;13:1812816. doi: 10.3389/fcvm.2026.1812816. eCollection 2026.ABSTRACTThere is a growing burden of cardiovascular diseases (CVDs) in sub-Saharan Africa (SSA). CVDs such as coronary artery disease, valvular heart disease, heart block and others require procedures invo

Nan Ma il 28/05/2026

Case Report: Cardiac metastasis of sarcomatoid urothelial carcinoma

Front Oncol. 2026 May 12;16:1763282. doi: 10.3389/fonc.2026.1763282. eCollection 2026.ABSTRACTBACKGROUND: Sarcomatoid urothelial carcinoma (SUC) is a rare, highly aggressive subtype of urothelial carcinoma (UC) accounting for fewer than 1%-2% of all urothelial malignancies. It is characterized by bi